| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurological Surgery (Drs. Kondziolka, and Jannetta), Neurology (Drs. Wechsler, Goldstein, Gebel, and S. DeCesare), Radiology (Drs. Meltzer and Thulborn), and Pathology (Dr. Elder), and the Stroke Institute (Drs. Kondziolka, Wechsler, Goldstein, Gebel, and DeCesare), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and Layton BioScience, Inc. (Drs. McGrogan, Reitman, and Bynum), Sunnyvale, California.
Address correspondence and reprint requests to Dr. Douglas Kondziolka, Suite B-400, UPMC, 200 Lothrop Street, Pittsburgh, PA 15213.
Transplantation of cultured neuronal cells is safe in animal models and improves motor and cognitive deficits in rats with stroke. The authors studied the safety and feasibility of human neuronal cellular transplantation in patients with basal ganglia stroke and fixed motor deficits, including 12 patients (aged 44 to 75 years) with an infarct 6 months to 6 years previously (stable for at least 2 months). Serial evaluations (12 to 18 months) showed no adverse cell-related serologic or imaging-defined effects. The total European Stroke Scale score improved in six patients (3 to 10 points), with a mean improvement 2.9 points in all patients (p = 0.046). Six of 11 PET scans at 6 months showed improved fluorodeoxyglucose uptake at the implant site. Neuronal transplantation is feasible in patients with motor infarction.
This article has been cited by other articles:
|
|
 |
|
  P. Stroemer, S. Patel, A. Hope, C. Oliveira, K. Pollock, and J. Sinden The Neural Stem Cell Line CTX0E03 Promotes Behavioral Recovery and Endogenous Neurogenesis After Experimental Stroke in a Dose-Dependent Fashion Neurorehabil Neural Repair, November 1, 2009; 23(9): 895 - 909. [Abstract] [PDF]
|
|
|
|
 |
|
 L. R. Wechsler Clinical Trials of Stroke Therapy: Which Cells, Which Patients? Stroke, March 1, 2009; 40(3_suppl_1): S149 - S151. [Full Text] [PDF]
|
|
|
|
|
|
The STEPS Participants Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): Bridging Basic and Clinical Science for Cellular and Neurogenic Factor Therapy in Treating Stroke Stroke, February 1, 2009; 40(2): 510 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Walczak, J. Zhang, A. A. Gilad, D. A. Kedziorek, J. Ruiz-Cabello, R. G. Young, M. F. Pittenger, P. C.M. van Zijl, J. Huang, and J. W.M. Bulte Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient Ischemia Stroke, May 1, 2008; 39(5): 1569 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Guzman, A. De Los Angeles, S. Cheshier, R. Choi, S. Hoang, J. Liauw, B. Schaar, and G. Steinberg Intracarotid Injection of Fluorescence Activated Cell-Sorted CD49d-Positive Neural Stem Cells Improves Targeted Cell Delivery and Behavior After Stroke in a Mouse Stroke Model Stroke, April 1, 2008; 39(4): 1300 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bliss, R. Guzman, M. Daadi, and G. K. Steinberg Cell Transplantation Therapy for Stroke Stroke, February 1, 2007; 38(2): 817 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-C. Shyu, S.-Z. Lin, C.-C. Lee, D. D. Liu, and H. Li Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial Can. Med. Assoc. J., March 28, 2006; 174(7): 927 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Zhang, Z. G. Zhang, and M. Chopp Neurogenesis in the Adult Ischemic Brain: Generation, Migration, Survival, and Restorative Therapy Neuroscientist, October 1, 2005; 11(5): 408 - 416. [Abstract] [PDF]
|
|
|
|
|
|
O. Lindvall and Z. Kokaia Recovery and Rehabilitation in Stroke: Stem Cells Stroke, November 1, 2004; 35(11_suppl_1): 2691 - 2694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Stilley, C. M. Ryan, D. Kondziolka, A. Bender, S. DeCesare, and L. Wechsler Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke Neurology, October 12, 2004; 63(7): 1320 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. V. Borlongan, S. J.M. Skinner, M. Geaney, A. V. Vasconcellos, R. B. Elliott, and D. F. Emerich Intracerebral Transplantation of Porcine Choroid Plexus Provides Structural and Functional Neuroprotection in a Rodent Model of Stroke Stroke, September 1, 2004; 35(9): 2206 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kelly, T. M. Bliss, A. K. Shah, G. H. Sun, M. Ma, W. C. Foo, J. Masel, M. A. Yenari, I. L. Weissman, N. Uchida, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex PNAS, August 10, 2004; 101(32): 11839 - 11844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-W. Jeong, K. Chu, K.-H. Jung, S. U. Kim, M. Kim, and J.-K. Roh Human Neural Stem Cell Transplantation Promotes Functional Recovery in Rats With Experimental Intracerebral Hemorrhage Stroke, September 1, 2003; 34(9): 2258 - 2263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Wechsler and D. Kondziolka Cell Therapy: Replacement Stroke, August 1, 2003; 34(8): 2081 - 2082. [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Kerr, J. Llado, M. J. Shamblott, N. J. Maragakis, D. N. Irani, T. O. Crawford, C. Krishnan, S. Dike, J. D. Gearhart, and J. D. Rothstein Human Embryonic Germ Cell Derivatives Facilitate Motor Recovery of Rats with Diffuse Motor Neuron Injury J. Neurosci., June 15, 2003; 23(12): 5131 - 5140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R A Barker, M Jain, R J E Armstrong, and M A Caldwell Stem cells and neurological disease J. Neurol. Neurosurg. Psychiatry, May 1, 2003; 74(5): 553 - 557. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Passier and C. Mummery Origin and use of embryonic and adult stem cells in differentiation and tissue repair Cardiovasc Res, May 1, 2003; 58(2): 324 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. d. Wert and C. Mummery Human embryonic stem cells: research, ethics and policy Hum. Reprod., April 1, 2003; 18(4): 672 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Rempe and T. A. Kent Using bone marrow stromal cells for treatment of stroke Neurology, August 27, 2002; 59(4): 486 - 486. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Gladstone, S. E. Black, and A. M. Hakim Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions Stroke, August 1, 2002; 33(8): 2123 - 2136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hallett Recent Advances in Stroke Rehabilitation Neurorehabil Neural Repair, June 1, 2002; 16(2): 211 - 217. [PDF]
|
|
|
|
 |
|
 P. T. Nelson, D. Kondziolka, L. Wechsler, S. Goldstein, J. Gebel, S. DeCesare, E. M. Elder, P. J. Zhang, A. Jacobs, M. McGrogan, et al. Clonal Human (hNT) Neuron Grafts for Stroke Therapy : Neuropathology in a Patient 27 Months after Implantation Am. J. Pathol., April 1, 2002; 160(4): 1201 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Veizovic, J. S. Beech, R. P. Stroemer, W. P. Watson, and H. Hodges Resolution of Stroke Deficits Following Contralateral Grafts of Conditionally Immortal Neuroepithelial Stem Cells Stroke, April 1, 2001; 32(4): 1012 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Buchan, D. Warren, R. Burnstein, and D. Kondziolka Transplantation of cultured human neuronal cells for patients with stroke Neurology, March 27, 2001; 56(6): 820 - 823. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Zivin Cell transplant therapy for stroke: Hope or hype Neurology, August 22, 2000; 55(4): 467 - 467. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
